Cargando…

Monocytes in Tumorigenesis and Tumor Immunotherapy

Monocytes are highly plastic innate immune cells that display significant heterogeneity during homeostasis, inflammation, and tumorigenesis. Tumor-induced systemic and local microenvironmental changes influence the phenotype, differentiation, and distribution of monocytes. Meanwhile, monocytes and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiaodie, Li, Yunqing, Xia, Houjun, Chen, Youhai H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340267/ https://www.ncbi.nlm.nih.gov/pubmed/37443711 http://dx.doi.org/10.3390/cells12131673

Ejemplares similares

Peritoneal resident macrophages in tumor metastasis and immunotherapy
por: Zhang, Yu, et al.
Publicado: (2022)

Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
por: Lian, Xin, et al.
Publicado: (2022)

Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications
por: Zhu, Shunyao, et al.
Publicado: (2021)

Monocytes reprogrammed by tumor microparticle vaccine inhibit tumorigenesis and tumor development
por: Sun, Weiwei, et al.
Publicado: (2023)

TNFAIP8 protein functions as a tumor suppressor in inflammation-associated colorectal tumorigenesis
por: Lou, Yunwei, et al.
Publicado: (2022)

Role of tumor microenvironment in tumorigenesis
por: Wang, Maonan, et al.
Publicado: (2017)

The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
por: Xu, Yichi, et al.
Publicado: (2020)

Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
por: Fendl, B., et al.
Publicado: (2023)

Tumor-infiltrating CCR2(+) inflammatory monocytes counteract specific immunotherapy
por: Bartneck, Joschka, et al.
Publicado: (2023)

Surface-Engineered Monocyte Immunotherapy Combined Graphene Quantum Dots Effective Against Solid Tumor Targets
por: Xia, Qing, et al.
Publicado: (2023)

Role of DKK4 in Tumorigenesis and Tumor Progression
por: Cai, Xinjia, et al.
Publicado: (2018)

TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis
por: Yan, Dehong, et al.
Publicado: (2019)

The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
por: Dzobo, Kevin, et al.
Publicado: (2023)

The Role of Inhaled Anesthetics in Tumorigenesis and Tumor Immunity
por: Xu, Yichi, et al.
Publicado: (2020)

Dynamic CD8(+) T Cell Cooperation with Macrophages and Monocytes for Successful Cancer Immunotherapy
por: Vermare, Anaïs, et al.
Publicado: (2022)

Tumor microenvironment and immunotherapy of oral cancer
por: Liu, Chang, et al.
Publicado: (2022)

Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells
por: Kim, Dae Suk, et al.
Publicado: (2011)

Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
por: Shunxi, Wang, et al.
Publicado: (2023)

Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment
por: Hopewell, Emily L., et al.
Publicado: (2020)

Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity
por: Njunge, Lucy Wanjiru, et al.
Publicado: (2020)

The Role of DACT Family Members in Tumorigenesis and Tumor Progression
por: Zeng, Yu, et al.
Publicado: (2022)

Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
por: Chen, Qinjun, et al.
Publicado: (2021)

Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy
por: Meng, Mao-Bin, et al.
Publicado: (2016)

Role of Galectins in Tumors and in Clinical Immunotherapy
por: Chou, Feng-Cheng, et al.
Publicado: (2018)

Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy
por: Vilgelm, Anna E., et al.
Publicado: (2019)

Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
por: He, Yunbo, et al.
Publicado: (2022)

Tumor Antigenicity and Approaches to Tumor Immunotherapy
por: Hewitt, H. B.
Publicado: (1980)

Understanding the Dual Roles of CircHIPK3 in Tumorigenesis and Tumor Progression
por: Wei, Zeyu, et al.
Publicado: (2022)

Oncogenic virus-induced aerobic glycolysis and tumorigenesis
por: Yu, Li, et al.
Publicado: (2018)

Progress in research on paclitaxel and tumor immunotherapy
por: Zhu, Linyan, et al.
Publicado: (2019)

Memory T cells: strategies for optimizing tumor immunotherapy
por: Liu, Qingjun, et al.
Publicado: (2020)

Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression
por: Wei, Jianxia, et al.
Publicado: (2023)

Role of the tumor immune microenvironment in tumor immunotherapy
por: Zhou, Changsheng, et al.
Publicado: (2022)

Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis
por: Bi, Qing, et al.
Publicado: (2022)

Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis
por: Lagopati, Nefeli, et al.
Publicado: (2021)

Emerging biomaterials for tumor immunotherapy
por: Xiao, Minna, et al.
Publicado: (2023)

Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy
por: Lei, Josh Haipeng, et al.
Publicado: (2021)

Role of ferroptosis on tumor progression and immunotherapy
por: Gong, Deting, et al.
Publicado: (2022)

E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies
por: Wang, Maoyu, et al.
Publicado: (2023)

Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies
por: Zhu, Haipeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_780fdct7944b4dirnlpv3r0650